INVENTOR • Navindra P. Seeram, Liya Li, Geneviéve Béland, Julie Barbeau
The present invention describes phytochemicals present in maple syrup and maple tree extracts by butanol, ethyl acetate and methanol. Novel compounds are isolated from maple syrups, including one compound Quebecol generated in the maple syrup manufacturing process. Also described are digesting extracts of maple syrup.
The phytochemicals may be used for the treatment or prevention of cancers, metabolic syndromes (a combination of medical disorders that, when occurring together, increase the risk of developing cardiovascular disease and diabetes), diabetes, microorganism infections and/or antioxidants. Neurodegenerative disease, oxidative stress-related disease, intestinal dysfunction, heart disease, cancer, and inflammatory conditions such as Crohn’s disease, ulcerative colitis, collagenous colitis, lymphocytic colitis, ischaemic colitis, diversion colitis, Behcet’s disease, and indeterminate colitis.
FEATURES & BENEFITS
•Type-2 diabetes management capability, via inhibition of carbohydrate hydrolyzing enzymes.
•Human cancer cell antiproliferative and anti-inflammatory properties.
•High level of antioxidant activity
Technology is available for licensing.